Wdowiak Krystian, Drab Agnieszka, Filipek Paulina, Religioni Urszula
Faculty of Medicine, Medical University of Lublin, University Clinical Hospital No. 4 in Lublin, K. Jaczewskiego 8 St., 20-954 Lublin, Poland.
Department of Medical Informatics and Statistics with e-Health Lab, Medical University of Lublin, 20-059 Lublin, Poland.
J Pers Med. 2024 Dec 4;14(12):1139. doi: 10.3390/jpm14121139.
: Cervical cancer is the fourth most commonly diagnosed malignant tumor in women and the fourth leading cause of cancer-related deaths among this population. Since it is asymptomatic in its early stages, preventive screening plays a crucial role in rapid diagnosis. Such screenings are conducted in many countries worldwide, although their popularity varies. Given that nearly all cases of cervical cancer are linked to high-risk human papillomavirus (hrHPV) infection, vaccination against this virus could lead to a significant reduction in cancer incidence. It should be noted that the level of vaccination coverage against hrHPV varies significantly between countries, ranging from a few percent to over 90%. Globally, the vaccination coverage of the target population is estimated at only a few percent. : This study was conducted using a proprietary, anonymous online questionnaire comprising 24 questions addressing various aspects of cervical cancer prevention. The newly designed questionnaire comprised 19 primary questions and 5 metric questions. The collected data were subjected to descriptive and statistical analysis. : The majority of respondents reported regularly participating in cervical cytology screening and gynecological visits. Non-participation in these screenings was primarily reported by younger respondents, not all of whom had indications for undergoing such examinations. Only 14% of the women surveyed had been vaccinated against hrHPV. However, it should be noted that, as the surveyed women were not covered by the relatively recently introduced vaccination program, they received their vaccinations through local programs conducted by certain cities or through private healthcare services. The respondents' primary sources of information on cervical cancer are the internet and medical personnel. : The level of knowledge among the women surveyed regarding cervical cancer prevention was satisfactory, though improvement is needed in some areas. Despite relatively good awareness of HPV's role in cervical cancer development, the popularity of HPV vaccination remains unsatisfactory. The results should be interpreted with caution due to the small study group.
宫颈癌是女性中第四大最常被诊断出的恶性肿瘤，也是该人群中与癌症相关死亡的第四大主要原因。由于其早期无症状，预防性筛查在快速诊断中起着至关重要的作用。尽管全球许多国家都开展了此类筛查，但其普及程度各不相同。鉴于几乎所有宫颈癌病例都与高危型人乳头瘤病毒（hrHPV）感染有关，针对该病毒的疫苗接种可显著降低癌症发病率。应当指出的是，各国针对hrHPV的疫苗接种覆盖率差异很大，从百分之几到90%以上不等。在全球范围内，目标人群的疫苗接种覆盖率估计仅为百分之几。
本研究使用了一份专有的匿名在线问卷，该问卷包含24个涉及宫颈癌预防各个方面的问题。新设计的问卷包括19个主要问题和5个计量问题。对收集到的数据进行了描述性和统计分析。
大多数受访者报告定期参加宫颈细胞学筛查和妇科检查。未参加这些筛查的主要是年轻受访者，其中并非所有人都有进行此类检查的指征。在接受调查的女性中，只有14%接种了针对hrHPV的疫苗。然而，应当指出的是，由于接受调查的女性未被相对近期推出的疫苗接种计划覆盖，她们是通过某些城市开展的地方计划或通过私人医疗服务接种疫苗的。受访者关于宫颈癌的主要信息来源是互联网和医务人员。
接受调查的女性对宫颈癌预防的知识水平令人满意，不过在某些方面仍需改进。尽管对HPV在宫颈癌发展中的作用有相对较好的认识，但HPV疫苗接种的普及程度仍不尽如人意。由于研究小组规模较小，对结果的解读应谨慎。
